165 related articles for article (PubMed ID: 38891882)
1. Advances in Anti-Cancer Drug Development: Metformin as Anti-Angiogenic Supplemental Treatment for Glioblastoma.
Shah S; Mansour HM; Aguilar TM; Lucke-Wold B
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891882
[TBL] [Abstract][Full Text] [Related]
2. Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in Glioblastoma.
Guarnaccia L; Marfia G; Masseroli MM; Navone SE; Balsamo M; Caroli M; Valtorta S; Moresco RM; Campanella R; Garzia E; Riboni L; Locatelli M
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008275
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic therapy for high-grade glioma.
Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008218. PubMed ID: 30480778
[TBL] [Abstract][Full Text] [Related]
4. Glioblastoma stem cells: a new target for metformin and arsenic trioxide.
Carmignani M; Volpe AR; Aldea M; Soritau O; Irimie A; Florian IS; Tomuleasa C; Baritchii A; Petrushev B; Crisan G; Valle G
J Biol Regul Homeost Agents; 2014; 28(1):1-15. PubMed ID: 24750786
[TBL] [Abstract][Full Text] [Related]
5. Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.
Yu Z; Zhao G; Xie G; Zhao L; Chen Y; Yu H; Zhang Z; Li C; Li Y
Oncotarget; 2015 Oct; 6(32):32930-43. PubMed ID: 26431379
[TBL] [Abstract][Full Text] [Related]
6. Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current.
Gritti M; Würth R; Angelini M; Barbieri F; Peretti M; Pizzi E; Pattarozzi A; Carra E; Sirito R; Daga A; Curmi PM; Mazzanti M; Florio T
Oncotarget; 2014 Nov; 5(22):11252-68. PubMed ID: 25361004
[TBL] [Abstract][Full Text] [Related]
7. Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms.
Miletic H; Niclou SP; Johansson M; Bjerkvig R
Expert Opin Ther Targets; 2009 Apr; 13(4):455-68. PubMed ID: 19335067
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
9. Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma.
Ahir BK; Engelhard HH; Lakka SS
Mol Neurobiol; 2020 May; 57(5):2461-2478. PubMed ID: 32152825
[TBL] [Abstract][Full Text] [Related]
10. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
[TBL] [Abstract][Full Text] [Related]
11. Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt.
Würth R; Pattarozzi A; Gatti M; Bajetto A; Corsaro A; Parodi A; Sirito R; Massollo M; Marini C; Zona G; Fenoglio D; Sambuceti G; Filaci G; Daga A; Barbieri F; Florio T
Cell Cycle; 2013 Jan; 12(1):145-56. PubMed ID: 23255107
[TBL] [Abstract][Full Text] [Related]
12. The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy.
Mattei V; Santilli F; Martellucci S; Delle Monache S; Fabrizi J; Colapietro A; Angelucci A; Festuccia C
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917954
[TBL] [Abstract][Full Text] [Related]
13. Mefloquine as a dual inhibitor of glioblastoma angiogenesis and glioblastoma via disrupting lysosomal function.
Wan B; Wu Z; Zhang X; Huang B
Biochem Biophys Res Commun; 2021 Nov; 580():7-13. PubMed ID: 34607260
[TBL] [Abstract][Full Text] [Related]
14. The Potential Therapeutic Impact of Metformin in Glioblastoma Multiforme.
Sanati M; Aminyavari S; Mollazadeh H; Motamed-Sanaye A; Bibak B; Mohtashami E; Teng Y; Afshari AR; Sahebkar A
Curr Med Chem; 2023; 30(7):857-877. PubMed ID: 35796457
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response.
Sesen J; Dahan P; Scotland SJ; Saland E; Dang VT; Lemarié A; Tyler BM; Brem H; Toulas C; Cohen-Jonathan Moyal E; Sarry JE; Skuli N
PLoS One; 2015; 10(4):e0123721. PubMed ID: 25867026
[TBL] [Abstract][Full Text] [Related]
17. Anti-Angiogenics: Their Role in the Treatment of Glioblastoma.
Winkler F; Osswald M; Wick W
Oncol Res Treat; 2018; 41(4):181-186. PubMed ID: 29562225
[TBL] [Abstract][Full Text] [Related]
18. Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells.
Chang CH; Liu WT; Hung HC; Gean CY; Tsai HM; Su CL; Gean PW
BMC Cancer; 2017 Dec; 17(1):905. PubMed ID: 29284440
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic Targets for Glioblastoma Therapy from a Pre-Clinical Approach, Using Nanoformulations.
Nery de Albuquerque Rego G; da Hora Alves A; Penteado Nucci M; Bustamante Mamani J; Anselmo de Oliveira F; Gamarra LF
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599834
[TBL] [Abstract][Full Text] [Related]
20. Metformin plus sorafenib highly impacts temozolomide resistant glioblastoma stem-like cells.
Aldea MD; Petrushev B; Soritau O; Tomuleasa CI; Berindan-Neagoe I; Filip AG; Chereches G; Cenariu M; Craciun L; Tatomir C; Florian IS; Crivii CB; Kacso G
J BUON; 2014; 19(2):502-11. PubMed ID: 24965413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
